The Incidental Discovery of Follicular Thyroid Cancer with In-111 Pentetreotide Scintigraphy in a Patient with Carcinoid Tumor of the Lung

Giuseppe Villa, Giovanni B. Ratto, Marco Carletto, Hamed Rouhanifar, Arnoldo Piccardo, Luigi Tommasi, Vania Altrinetti, Carlo Mereu, Giuliano Mariani

Research output: Contribution to journalArticlepeer-review

Abstract

Although scintigraphy with the somatostatin receptor agent In-111 pentetreotide is most useful in patients with amine precursor uptake and decarboxylation-derived tumors, several reports note the tumor-targeting potential of this radiopharmaceutical in other types of cancers as well. The authors describe a 38-year-old woman with carcinoid tumor of the lung in whom scintigraphy with labeled pentetreotide was positive in the known lung tumor and incidentally revealed uptake in a thyroid nodule. Although the serum calcitonin level was normal, fine-needle cytology of the thyroid nodule was consistent with follicular cancer. The patient underwent resection of the lower lobe of the left lung and total thyroidectomy, which confirmed a follicular cancer in the right thyroid lobe.

Original languageEnglish
Pages (from-to)45-46
Number of pages2
JournalClinical Nuclear Medicine
Volume28
Issue number1
DOIs
Publication statusPublished - Jan 2003

Keywords

  • Carcinoid Tumor
  • Follicular Thyroid Cancer
  • In-111 Pentetreotide
  • Somatostatin Receptor Scintigraphy

ASJC Scopus subject areas

  • Radiology Nuclear Medicine and imaging
  • Radiological and Ultrasound Technology

Fingerprint Dive into the research topics of 'The Incidental Discovery of Follicular Thyroid Cancer with In-111 Pentetreotide Scintigraphy in a Patient with Carcinoid Tumor of the Lung'. Together they form a unique fingerprint.

Cite this